CHARLES M BALCH to Predictive Value of Tests
This is a "connection" page, showing publications CHARLES M BALCH has written about Predictive Value of Tests.
Connection Strength
0.251
-
Uncertainties in the management of melanoma nodal metastasis. Eur J Surg Oncol. 2015 Jul; 41(7):811-3.
Score: 0.070
-
Predicting outcomes in metastatic melanoma. J Clin Oncol. 2008 Jan 10; 26(2):168-9.
Score: 0.042
-
Can completion lymph node dissection be avoided for a positive sentinel node in melanoma? Ann Surg Oncol. 2007 Sep; 14(9):2437-9.
Score: 0.041
-
New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol. 2003; 21(1):43-52.
Score: 0.030
-
Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018 02 01; 36(4):399-413.
Score: 0.021
-
Polymerase chain reaction for detection of melanoma in peripheral blood: too early to assess clinical value. J Natl Cancer Inst. 1996 May 01; 88(9):569-70.
Score: 0.019
-
2010 TNM staging system for cutaneous melanoma...and beyond. Ann Surg Oncol. 2010 Jun; 17(6):1475-7.
Score: 0.012
-
An integrated tree-based classification approach to prognostic grouping with application to localized melanoma patients. J Biopharm Stat. 2007; 17(3):445-60.
Score: 0.010
-
The new melanoma staging system. Cancer Control. 2002 Jan-Feb; 9(1):9-15.
Score: 0.007